Let's work through the guidelines with this objection from a physician:

"Historically, with OCs, the lower the estrogen dose, the higher the rates of breakthrough bleeding (BTB) and spotting. Now, you're telling me that with a daily dose of 15mg EE with NuvaRing^®, cycle control may be even better than with OCs with more EE. I find that hard to believe, especially since the BTB rates with the patch are similar to OCs, and it has 20mg EE."

Click each guideline topic below to see how you would walk through this objection.